When billing CPT code 96372, ensure the following are included in the medical record: Name and dosage of the drug administered Route of administration (subcutaneous or intramuscular) Site of injection Time and date of service Reason for the injection (diagnosis or medical necessity) Signature and credentials of the administering provider Accurate and complete documentation supports the claim, validates medical necessity, and helps protect against audits and reimbursement issues
Patients who do respond meaningfully to the combination may continue cycling AOD-9604 in defined patterns (typically with the 4 to 8 week break between cycles) for as long as the response remains clinically useful
Endometriosis is a risk factor for infertility
BPC-157 formally Body Protection Compound 157 is a synthetic 15-amino acid peptide with the sequence GEPPPGKPADDAGLV
Caution is advised in patients with Leber optic atrophy, a genetic disorder caused by chronic cyanide intoxication (such as from smoking, alcohol or some plants), against the use of cyano-B12 due to its cyanide moiety, whilst hydroxo-B12 is a cyanide antagonist and can therefore be used in these patients
Study Identification and Selection Approach The initial search yielded a large body of literature across peptide agents and clinical domains